Elkar solution for oral administration - official* instructions for use. "Elkar": reviews on the use of the drug, composition, instructions

Included complex therapy:

Intense physical activity and psycho-emotional stress: to increase performance, endurance, reduce fatigue, incl. in elderly people;

During the period of rehabilitation after illnesses and surgical interventions, injuries, incl. to accelerate tissue regeneration;

Complex therapy chronic gastritis with decreased secretory function and chronic pancreatitis with exocrine insufficiency;

Complex therapy skin diseases(psoriasis, seborrheic eczema, focal scleroderma, discoid lupus erythematosus);

Hyperthyroidism mild degree;

Neurological manifestations in brain lesions of vascular, toxic and traumatic origin;

Syndrome anorexia nervosa;

Diseases accompanied by a lack of carnitine or its increased loss (including myopathies, cardiomyopathies, mitochondrial diseases, hereditary diseases with concomitant mitochondrial deficiency) - to compensate for its deficiency as part of complex therapy.

IN pediatric practice(treatment of children under 3 years of age under medical supervision):

Nursing premature babies and newborns who have suffered birth trauma or asphyxia;

Children with a sluggish sucking reflex and low weight gain, reduced muscle tone, with insufficient development of motor and mental functions, as well as for the purpose of preventing these disorders in children at risk;

For stunted growth and underweight in children and adolescents under 16 years of age.

In adults in sports medicine and at intensive training(during the training process when working on aerobic performance):

To improve speed-strength indicators and coordination of movements;

For increase muscle mass and reduction of body fat mass;

To prevent post-training syndrome (accelerated recovery processes after physical activity);

At traumatic injuries in order to accelerate muscle regeneration.

Release form of the drug Elkar

oral solution 200 mg/ml; dark glass bottle (bottle) 50 ml, box (box) 1;
oral solution 200 mg/ml; bottle (bottle) of dark glass 100 ml, box (box) 1;
oral solution 200 mg/ml; dark glass dropper bottle 25 ml, box (box) 1;
oral solution 300 mg/ml; dark glass bottle (bottle) 100 ml with measuring cup (cup), cardboard pack 1;
oral solution 300 mg/ml; dark glass bottle (flacon) 50 ml with measuring spoon (scoop), cardboard pack 1;
oral solution 300 mg/ml; dark glass dropper bottle 25 ml, cardboard pack 1;
oral solution 300 mg/ml; plastic bottle (bottle) 25 ml, cardboard pack 10;
oral solution 300 mg/ml; plastic bottle (bottle) 25 ml, cardboard pack 20;

Compound
Oral solution 1 ml
active substance:
levocarnitine (carnifit) 300 mg
Excipients: citric acid monohydrate - 1.2 mg; methyl parahydroxybenzoate - 0.5 mg, propyl parahydroxybenzoate - 0.2 mg; purified water - up to 1 ml
in dark glass dropper bottles of 25 ml; 1 bottle in a cardboard pack;

In plastic bottles of 25 ml; in a cardboard pack there are 10 or 20 bottles;

In dark glass bottles of 50 ml with a measuring spoon with a nominal volume of 5 ml and with a mark marked “1/2” (which corresponds to 2.5 ml) or with a measuring spoon with a nominal volume of 5 ml with marks marked “1/4” and “1/2” (which corresponds to 1.25 and 2.5 ml); 1 bottle in a cardboard pack;

In dark glass bottles of 100 ml with a measuring cup of 20 ml; 1 bottle in a cardboard pack.

Pharmacodynamics of the drug Elkar

A drug for the correction of metabolic processes.

L-carnitine is a natural substance related to B vitamins. Participates in metabolic processes as a carrier of long-chain fatty acids(including palmitic) through cell membranes from the cytoplasm to the mitochondria, where these acids undergo the process of β-oxidation with the formation of ATP and acetyl-CoA.

Improves protein and fat metabolism, increases secretion and enzymatic activity gastric and intestinal juices, improves food absorption, reduces overweight body and reduces fat content in muscles. Increases resistance to physical exercise, inhibits the formation of ketoacids and anaerobic glycolysis, reduces the degree of lactic acidosis, promotes economical consumption of glycogen and increases its reserves in the liver and muscles.

Elcar® has anabolic and lipolytic effects. Normalizes increased basal metabolism in hyperthyroidism, being a peripheral (indirect) antagonist of the action of thyroid hormones, and not a direct inhibitor of thyroid function.

Improves metabolism and energy supply to tissues.

Pharmacokinetics of the drug Elkar

Suction and distribution

After oral administration, it is well absorbed in the intestine, Cmax is reached after 3 hours. Therapeutic concentration is maintained for 9 hours. It penetrates well into the liver, myocardium, and more slowly into the muscles.

Metabolism and excretion

It is excreted by the kidneys, mainly in the form of acyl esters.

Use of the drug Elkar during pregnancy

Due to the lack of research, use during pregnancy and lactation is not recommended. Needs to stop breast-feeding during the period of use of the drug.

Contraindications to the use of the drug Elkar

Individual intolerance.

Side effects of the drug Elkar

From the outside digestive system: gastralgia, dyspepsia.

Other: allergic reactions, myasthenia gravis (in patients with uremia) are possible.

Method of administration and dosage of the drug Elkar

The drug is taken orally 30 minutes before meals, further diluted with liquid.

For adults with prolonged physical and psycho-emotional stress, the drug is prescribed in a dose of 750 mg (1/2 measuring spoon or 2.5 ml) 3 times a day to 2.25 g (1.5 measuring spoon or 7.5 ml) 2-3 times a day.

For anorexia nervosa, as well as during the rehabilitation period after illnesses and surgical interventions and injuries - 1.5 g (1 scoop or 5 ml) 2 times a day. The course of treatment is for 1-2 months.

In complex therapy of chronic gastritis and chronic pancreatitis with reduced secretory function, the drug is prescribed 375 mg (1/4 scoop or 1.25 ml) 2 times a day. The course of treatment is for 1-1.5 months.

For the treatment of skin diseases - 750 mg (1/2 scoop or 2.5 ml). The course of treatment is for 2-4 weeks.

For mild hyperthyroidism, the drug is prescribed 250 mg (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or used for 3 months without a break.

For brain lesions of vascular, toxic and traumatic origin - 750 mg (1/2 scoop or 2.5 ml)/day. The course of treatment is for 3-5 days. If necessary, a repeat course is prescribed after 12-14 days.

For diseases accompanied by a lack of carnitine (primary and secondary carnitine deficiency), the drug is prescribed in a dose of up to 50-100 mg/kg (2-5 drops/kg) of body weight. Frequency of administration - 2-3 times/day. The course of treatment is for 3-4 months.

For children, the drug is prescribed as an additive to sweet dishes (jelly, compote, juices).

For children under 3 years of age, the dosage regimen is determined individually. Children from 3 to 6 years old - in a single dose of 100 mg (5 drops) 2-3 times a day, daily dose- 200-300 mg (11-16 drops). The course of treatment is 1 month. Children aged 6 to 12 years are prescribed a single dose of 200-300 mg (11-16 drops) 2-3 times a day, a daily dose of 400-900 mg. The course of treatment is at least 1 month.

For growth retardation - 250 mg (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or prescribed for 3 months without a break.

For adults in sports medicine and during intense training, 2.5 g is prescribed 1-3 times a day (daily dose 2.5-7.5 g); in case of use with therapeutic purpose- 70-100 mg/kg/day (5-7.5 g/day). Reception courses: 3-4 weeks in the pre-competition period, during the training process - up to 6-8 weeks.

Overdose of Elkar

Symptoms: dyspeptic disorders, myasthenic disorders (in patients with uremia).

Treatment: gastric lavage, taking activated carbon.

Interactions of the drug Elkar with other drugs

At simultaneous use GCS promote the accumulation of carnitine in tissues (except the liver), anabolic agents enhance the effect of the drug.

Special instructions when taking Elkar

Use in pediatrics

Treatment of children under 3 years of age should be carried out under medical supervision.

Impact on the ability to drive vehicles and operate machinery

The drug has no effect on the performance of potentially dangerous species activities requiring special attention and speed of psychomotor reactions (driving a car and other vehicles, work with moving mechanisms, work of the dispatcher and operator, etc.)

Storage conditions for the drug Elkar

In a place protected from light, at a temperature of 15–25 °C.

Shelf life of the drug Elkar

The drug Elkar belongs to the ATX classification:

A Digestive tract and metabolism

A16 Other drugs for the treatment of gastrointestinal diseases and metabolic disorders

A16A Other drugs for the treatment of gastrointestinal diseases and metabolic disorders

A16AA Amino acids and their derivatives

IN modern world we are constantly faced with different stressful situations, we don’t have time to comply correct mode nutrition, are exposed to intense stress, and also work in chronic fatigue. All this leads to deterioration in the functioning of the body, metabolic disorders, decreased ability to work and the manifestation of neuroses.

To normalize metabolism and energy supply to tissues, the drug "Elkar" (in the international classification - "Levocarnitine") was created. The active ingredient of "Elkara" - L-carnitine - is a product of organic origin, which is similar in its effect to B vitamins.

"Elkar" promotes the breakdown of fat cells, increases the secretory productivity of the gastrointestinal tract and improves metabolism.

In this article we will tell you how to take Elkar and for what purposes.

Indications for use

Taking Elkar is indicated as a complex therapy for many diseases, but it is mainly used:

• to normalize the secretory function of the gastrointestinal tract;
• V various states in which there is a deficiency of carnitine or a decrease in its level in the body (mitochondrial diseases, myopathy);
• to improve tissue repair;
• as a preventive measure and aid for the treatment of various skin diseases;
• for the treatment of hyperthyroidism;
• in therapy neurological manifestations for brain damage of various nature;
• with loss of appetite nervous soil;
• to improve performance.

Dosage of the drug

"Elkar" is produced in the form of a solution for internal reception. It should be taken 30 minutes before meals. The dosage depends on the patient's age.

• For adults, the drug is prescribed in a volume of 750 mg. (half a scoop or 2.5 ml.) 2-3 times a day for 1-2 months.
• Elkar is prescribed for children as an additive to dishes containing sugar (juices, compotes). At the age of 3 to 6 years, a child can be given 100 mg. the drug 2-3 times a day for one month. It is recommended to give 200-300 mg to children from 6 to 12 years old. "Elkara" 2-3 times a day. The course should last at least a month.
• "Elkar" for newborns: under the age of 3 years, the dosage of the drug is prescribed individually and only under the strict supervision of a doctor.

"Elkar" for weight loss

This drug also helps people who suffer from overweight, since it is able to influence metabolism. In view of this, many are interested in how to take Elkar for weight loss in order to get rid of extra pounds.

Especially for weight loss, "Elkar" is available in 100 ml bottles. Take two teaspoons, morning and evening, 30 minutes before meals. "Elkar" can be purchased at a pharmacy without a doctor's prescription.

Also on the market medicines There is an analogue of "Elkar" - the drug "Carnitine". You can read about it in the article.

Compound

pharmachologic effect

The drug has a pronounced anabolic and lipolytic effect. L-carnitine is a partial antagonist of thyroxine and helps normalize basal metabolism in patients with mild form hyperthyroidism.
L-carnitine is well absorbed into digestive tract. Active ingredient Elkar reaches maximum plasma concentrations 3 hours after oral administration. Therapeutic concentrations of L-carnitine remain in plasma for 9 hours. The active component penetrates well into the tissues of the liver and myocardium, as well as muscle tissue. Metabolized to form acyl esters, which are excreted by the kidneys.

Indications for use

Elkar is used in complex therapy of patients suffering from anorexia nervosa syndrome, as well as vascular, toxic and traumatic lesions brain with severe neurological symptoms.
The drug Elcar can be prescribed to compensate for L-carnitine deficiency in patients with myopathy, mitochondrial diseases and cardiomyopathy.
In pediatric practice, Elkar is used to improve the condition of premature babies and newborns who have suffered asphyxia or birth trauma, as well as to treat children with a weak sucking reflex, insufficient weight gain, low muscle tone, and insufficient development of motor and mental functions.

Elkar is also used in pediatric practice to treat children under 16 years of age suffering from growth retardation or underweight.
In sports medicine, Elkar is used for intense training, as well as to improve speed-strength performance and coordination of movements, to reduce body fat mass and increase muscle mass, and to prevent post-training syndrome.

Mode of application

At chronic forms pancreatitis and gastritis with reduced secretory activity, as a rule, it is recommended to take 1.25 ml of solution twice a day. The recommended duration of a course of taking L-carnitine is 1-1.5 months.
For skin diseases, as a rule, it is recommended to take 2.5 ml of solution per day. The recommended duration of a course of taking L-carnitine is 2-4 weeks.
For mild hyperthyroidism, it is usually recommended to take 0.8 ml of solution (13 drops) twice or thrice a day. The recommended duration of a course of taking L-carnitine is 20 days. If necessary, the course of taking Elkar is repeated.

For brain lesions with severe neurological symptoms, as a rule, it is recommended to take 2.5 ml of solution per day. The recommended duration of a course of taking L-carnitine is 3-5 days. The course of treatment is repeated after 12-14 days.
In case of carnitine deficiency, as a rule, it is recommended to take 2-5 drops/kg body weight twice or thrice a day. The recommended duration of a course of taking L-carnitine is 3-4 months.
In pediatric practice, it is recommended to dilute the solution with compote or juice.
For children under 3 years of age, the dose of L-carnitine should be determined individually.

Children from 3 to 6 years old are usually prescribed 5 drops of solution twice or thrice a day.
Children from 6 to 12 years old are usually prescribed 11-16 drops twice or thrice a day.
The recommended duration of a course of taking L-carnitine is 1 month.
In case of growth retardation, it is recommended to prescribe 13 drops of solution twice or thrice a day for 20 days. If necessary, the course of taking Elkar is repeated.
In sports medicine, as a rule, 1.25 ml of solution is used 1 to 3 times a day. After injuries, the dose is increased to 70-100 mg/kg body weight per day. The duration of the course is 3-4 weeks, during the training process - from 6 to 8 weeks.

Side effects

Contraindications

Pregnancy

Drug interactions

Overdose

Release form

Storage conditions

Synonyms

Active substance:

Information about the drug is provided for informational purposes only and should not be used as a guide to self-medication. Only a doctor can decide to prescribe the drug, as well as determine the dose and methods of its use.

Country of origin

Product group

A drug that improves metabolism and energy supply to tissues

Release forms

• 25 ml - dark glass dropper bottle (1) - cardboard packs. 25 ml - dark glass dropper bottle (10) - cardboard packs. 60 capsules per pack; granules for preparing a solution for oral administration, 900 mg each - in one sachet 5 g - 10 pcs per pack. pack of 10 ampoules of 5 ml pack of 10 ampoules of 5 ml bottle 100 ml in individual/pack bottle 50 ml in individual/pack

Description of the dosage form

• solution for intravenous and intramuscular injection solution for intravenous and intramuscular administration 30 capsules white+ 30 capsules white-red color. Oral solution effervescent granules for preparing a white or almost white solution

pharmachologic effect

Pharmacokinetics

Special conditions

Compound

• Composition of the white capsule with taurine and potassium: potassium citrate (stabilizer), taurine 250 mg, capsule shell (gelatin, titanium dioxide dye), lactose (filler), talc (anti-caking agent), calcium stearate (anti-caking agent). Composition of the white-red capsule with L-arginine and magnesium: L-arginine 295 mg, trisubstituted anhydrous magnesium dicitrate 13.5 mg, capsule shell (gelatin, dyes: titanium dioxide, quinoline yellow, azorubine), talc (anti-caking agent), lactose (filler), calcium stearate (anti-caking agent). 1 ml levocarnitine (carnifit) 300 mg Excipients: citric acid monohydrate - 1.2 mg, methyl parahydroxybenzoate - 0.5 mg, propyl parahydroxybenzoate - 0.2 mg, purified water - up to 1 ml. 1 ml levocarnitine (carnifit) 300 mg Excipients: citric acid monohydrate - 1.2 mg, methyl parahydroxybenzoate - 0.5 mg, propyl parahydroxybenzoate - 0.2 mg, purified water - up to 1 ml. Levocarnitine (Carnifit) - 0.1 g; excipient: water for injection - up to 1 ml.

Elkar indications for use

• Elkar is used as part of complex therapy for acute hypoxic conditions (acute cerebral hypoxia, ischemic stroke, transient ischemic attack). The drug is prescribed in acute, subacute and recovery periods of disorders cerebral circulation. Used for dyscirculatory encephalopathy and various traumatic and toxic lesions brain, in recovery period after surgical interventions. Elkar is indicated for primary and secondary carnitine deficiency, including in patients with chronic renal failure those on hemodialysis; with cardiomyopathy, coronary disease heart (angina, acute heart attack myocardium, post-infarction conditions), hypoperfusion due to cardiogenic shock and other metabolic disorders in the myocardium.

Amino acids and vitamin-like substances are activators of a wide variety of biological processes. One of these amino acids is L-carnitine (levocarnitine), which is structurally reminiscent of B vitamins.

Despite the fact that this amino acid is synthesized in the body, there are a number of diseases and developmental abnormalities in which there is a deficiency. In order to replenish the existing deficiency, the drug Elkar was synthesized.

Elkar-20, 30% is a universal corrector and stimulator of energy metabolism, which improves activity nervous system and brain structures in general; promotes recovery of the body after operations and diseases; improves the condition of organs and systems of the body; supports the ability to withstand high loads.

Elkar-20, 30% belongs to the group medicines, containing levocarnitine, which takes an active part in metabolism and the formation of human energy potential.

Elkar-20, 30% increases enzymatic activity and secretion of gastrointestinal juices, thereby improving food absorption.

Elcar is an analogue of L-carnitine, a carrier of fatty acids through cell membranes into mitochondria from the cytoplasm, where β-oxidative processes subsequently occur with the formation of ATP and acetyl-CoA.

Release form

The drug is available in bottles (25/50/100 ml) in the form of a colorless, transparent or lightly colored solution of various concentrations - 20 and 30% (Elkar 20 and Elkar 30 percent). A specific odor may be present when opening the bottle. Also available as a solution in ampoules of 5 ml and Elkar tablets (in the form of chewable tablets).

Elkar - composition and indications for use

The drug Elkar has the following composition:

• basic active substance– levocarnitine;
• excipients - methyl parahydroxybenzoate, propyl parahydroxybenzoate, citric acid monohydrate, purified water.

Indications for use of the drug Elkar - 20, 30%:

As a rule, it is part of complex therapy for the following conditions:

• intense psycho-emotional and physical stress, increased fatigue, reduced performance and endurance (especially in the elderly);
• during the period of rehabilitation after illnesses and surgical interventions;
• in complex therapy of diseases gastrointestinal tract, skin diseases, mild hyperthyroidism, traumatic and neurological lesions brain, with a lack of carnitine in the body.

The drug Elcar is widely prescribed to children. In pediatric practice, Elkar is indicated for children with a number of deviations from the norm in newborns.

Elkar is prescribed to children under one year of age when caring for newborns with birth trauma, premature babies who suffered asphyxia. Elkar is also prescribed for infants with insufficient development of mental and motor functions, with a sluggish sucking reflex, decreased muscle tone, low weight gain.

It is recommended to prescribe Elkar to children under one year of age and in order to prevent such disorders in children at risk. Elkar is recommended for children and older adults - children and adolescents under 16 years of age with underweight and stunted growth.

Elkar - application and dosage

The drug Elkar is used in the following dosages and methods:

1. Adults taking Elkar prescribed 30 minutes before meals, orally, diluted with additional liquid.

• for thyrotoxicosis and growth retardation - 0.25 g 3 times a day for 20 days;
• to increase appetite and weight gain in patients chronic pancreatitis and gastritis - 0.5 g 2 times a day, for 1-1.5 months;
• for prolonged high physical activity, a dose of 1-2 g is prescribed 2-3 times a day 30 minutes before meals.

2.Elkar for children, dosage:

• Elkar is prescribed to infants (up to one year old) 3 times in a single dose of 10 drops (0.075 g) per day as an additive to juices, jelly, compotes);
• Elkar for children under 2 years old with genetic diseases and primary/secondary deficiency are prescribed in doses of 0.15 g/kg/day, at the age of 2 to 6 years – in a dose of 0.1 g/kg/day;
• Elkar is prescribed to children 6-12 years old at a dose of 0.75 g/kg/day, and after 12 years to adults - at a dose of 2-4 g/kg/day.

Elkar is prescribed to children under 3 years of age under the supervision of a doctor. Elkar for children, the dosage can be prescribed individually depending on the age, disease and condition of the child.

Contraindications for use

Taking Elkar is contraindicated in the presence of individual intolerance (history of hypersensitivity) to the drug as a whole, or if the body is intolerant to taking individual components of Elkar. Due to the lack of reliable scientific research use of Elkar during pregnancy, as well as during breastfeeding without urgent need Not recommended.

Elkar - side effects

When taking the drug Elkar, side effects are possible in the form of allergic reactions, as well as from the gastrointestinal tract: pain in the epigastric region, dyspepsia. When identifying side effects Elkar should be discontinued or its dosage reduced.